Navigation Links
Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
Date:2/11/2009

a registered trademark of Sanofi/Aventis and Bristol Myers Squibb.

About Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals develops innovative therapeutics based on targets with established proof of concepts that are engineered to provide significant advances over current treatments for cardiovascular disease, inflammatory disease and cancer.

Portola's two lead Phase 2 compounds, betrixaban, an oral Factor Xa inhibitor and elinogrel (PRT060128), a P2Y12 ADP receptor antagonist, target the global multi-billion dollar antithrombotic market. Both product candidates have best-in-class features versus current products and novel agents in development and address the hospital, specialty, and chronic care markets. Portola's earlier-stage programs include efforts focused on the discovery and development of novel, specific Syk and JAK inhibitors to treat cancer and inflammatory diseases, and on a novel anticoagulant antidote program with the potential to help manage the more than 20 million patients expected to be treated with anticoagulants worldwide in the next decade. For additional information, visit www.portola.com.


'/>"/>
SOURCE Portola Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...orkingTogethertoShareRecordsSafely,ImproveCare ,...DepartmentofVeteransAffairs(VA)andKaiserPermanente...reandservicestoourNation,sheroes.VAandKaiserPerman...ealthrecord(EHR)informationusingtheNationwideHealt...ealthandHumanServices. ,, "Theabilitytosharecri...
(Date:11/25/2009)...ftistheLargestDonationEverMadeinSupportofFeedingAm...RNewswire-USNewswire/--FeedingAmerica,thenation,sl...illiondonationfromtheBankofAmericaCharitableFounda...ncomeAmericanswiththeSupplementalNutritionAssistan...hefundswillbeusedtohelpFeedingAmericafoodbanksimpr...
(Date:11/25/2009)... - Two signaling pathways essential to normal huma...al growth factor receptor (EGFR) pathways - intera...d metastasis, researchers from The University of T...v. 25 issue of Molecular Cell . , This newly ch...omponents known to correlate with invasive cancer ...
(Date:11/25/2009)...ES (Nov. 25, 2009) Melvin R. Kaplan, MD, FACP, a ...research institute that became Los Angeles Biomedi...er (LA BioMed), will be honored by the American Co...he care of patients. , At its April 22, 2010 mee...s will present Dr. Kaplan with the Ralph O. Claypo...
(Date:11/25/2009)...ov. 25, 2009 Physicians at UT Southwestern Medica...esigned to improve breathing in patients with uppe... them from breathing independently. , UT Southw...f only two sites in Texas and one of 25 in the cou...led the NeuRx Diaphragm Pacing System. , The dev...
Breaking Medicine News(10 mins):Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2
...b hoax calls are made by children as young as eigh...ried Delhi Police, battling a spate of prank calls... have done by seeking the help of psychiatrists. ...alling up the police control room. In the 13...
...Ranbaxy Laboratories and Aurobinda Pharma were amo...diagnostic companies applauded by UN Secretary Gen... access to HIV/AIDS treatment and prevention. ...United Nations Headquarters yesterday. Beside...
...s health authorities are in talks with doctors of ...recent employment rules that in effect make it vir... the National Health Service (NHS). As offic...udge has admitted the case filed in the high court...
...ay prevent many women from getting pregnant, but v...an restore fertility, a US researcher concluded.//...examined the value of psychological treatment for ...f 16 women was small and that a larger investigati...
... the wildly successful poster-child of a new gener... the cancer cell, can be dangerous to the heart.//...called tyrosine kinase inhibitors – could lead to ...sts led by Thomas Force, M.D., James C. Wilson Pro...
...are in charge of maintaining the water level in th...excreted out. When the kidneys get affected, it re...ch might lead to health complications and even chr...enal failure is not easy to detect and there are n...
Other Medicine News:Health News:Psychiatrist's Help Sought to Counsel Children Making Hoax Calls 2Health News:British Doctors Hold Talks to end Impasse of Indian doctors 2Health News:Stress Therapy can Restore Fertility: Study 2Health News:"Miracle" Cancer Drug Gleevec Can be Toxic to the Heart 2Health News:"Miracle" Cancer Drug Gleevec Can be Toxic to the Heart 3
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
(Date:11/25/2009)...,China,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSky...")(Nasdaq: CSKI ),a,leadingfullyintegratedpharmace...erdrugsinthePeople,sRepublicofChina("PRC"),today,a...onalInstitutefor,theControlofPharmaceuticalandBiol...roducts:itsDiagnosticKitforHumanProstateSpecific,A...
(Date:11/25/2009)...M,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniumR...ologymarketintelligence,thenearly$3billionUSmarket...thoverthenextfiveyearsdespitetherecenteconomicslow...indsthatthismarketwillremainhighlydynamicoverthene...evicesinpreviouslyunderservedsegmentsofthetraumafi...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 1Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 2Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 3Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 4Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 1Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 3Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 4Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 1Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 2Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 3Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 4
...new tool that works within minutes, upon European ...TH, N.J., June 2 Schering-Plough,Corporation (NYS...dicinal,Products for Human Use (CHMP) of the Europ...al of sugammadex for routine reversal of the muscl...iate reversal of rocuronium,in adults, and for rou...
... results of the Spare the,Nephron (STN) study, a m...ing treatment protocol using CellCept(R) (mycophen...in combination with sirolimus,(SRL) is associated ...e,CellCept-based regimen in combination with calci...showed this improvement without increasing the,ris...
Other Medicine Technology:European Union's CHMP Issues Positive Opinion on Sugammadex 2European Union's CHMP Issues Positive Opinion on Sugammadex 3European Union's CHMP Issues Positive Opinion on Sugammadex 4European Union's CHMP Issues Positive Opinion on Sugammadex 5Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 2Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 3Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 4Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 5
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: